Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Deducing the Role of TEADs in Acute Myeloid Leukemia
EF 2023-24
Résumé
Acute myeloid leukemia (AML) is a deadly blood cancer where patients often experience tumour regrowth due to drug resistance. The bone marrow protects AML cells via adhesion to blood vessel cells, facilitating tumour repopulation. Understanding what promotes adhesion is crucial to prevent this process and thus drug resistance. The TEAD family of DNA-binding proteins bind YAP to promote division in some human cancers. However, AML is a one of many YAP-negative (YAPoff) cancers, and TEAD function in this context is unclear. Studying YAPoff cancers other than AML, we found that many genes that promote adhesion are switched off, and TEADs bind these genes. We suspect that TEADs might silence these adhesion genes. Indeed, in these cancers we find that TEAD binds proteins known to switch off genes. Moreover, analyzing AML patient data, we found that bone marrow specific induction of TEAD-bound adhesion genes is associated with poor patient survival. Thus, I hypothesize that the bone marrow disrupts a TEAD-repressor protein complex in AML cells to promote adhesion and drug resistance. To test this idea, we created a unique set of molecular tools to deplete all four members of the TEAD family. I will deplete TEADs in AML cell to assess whether cells become adhesive and/or drug resistant. I will also leverage our expertise in uncovering TEAD partners to define whether, as in other YAPoff cancers, TEAD is associated with repressor proteins in AML. My project is the first to study TEAD function in AML and could uncover an entirely new mechanism of drug resistance. My work will expose the molecular network underpinning TEAD function, potentially revealing new therapeutic targets that could thwart drug resistance and improve patient survival in the clinic.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506200
Name
Wang Ming-Heng
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Deducing the Role of TEADs in Acute Myeloid Leukemia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Myeloid Leukemia; Bioid; Cell Adhesion; Crispri; Drug Resistance; Interactome; Tead Family Transcription Factors; Transcriptional Repression
Abstract
Acute myeloid leukemia (AML) is a deadly blood cancer where patients often experience tumour regrowth due to drug resistance. The bone marrow protects AML cells via adhesion to blood vessel cells, facilitating tumour repopulation. Understanding what promotes adhesion is crucial to prevent this process and thus drug resistance. The TEAD family of DNA-binding proteins bind YAP to promote division in some human cancers. However, AML is a one of many YAP-negative (YAPoff) cancers, and TEAD function in this context is unclear. Studying YAPoff cancers other than AML, we found that many genes that promote adhesion are switched off, and TEADs bind these genes. We suspect that TEADs might silence these adhesion genes. Indeed, in these cancers we find that TEAD binds proteins known to switch off genes. Moreover, analyzing AML patient data, we found that bone marrow specific induction of TEAD-bound adhesion genes is associated with poor patient survival. Thus, I hypothesize that the bone marrow disrupts a TEAD-repressor protein complex in AML cells to promote adhesion and drug resistance. To test this idea, we created a unique set of molecular tools to deplete all four members of the TEAD family. I will deplete TEADs in AML cell to assess whether cells become adhesive and/or drug resistant. I will also leverage our expertise in uncovering TEAD partners to define whether, as in other YAPoff cancers, TEAD is associated with repressor proteins in AML. My project is the first to study TEAD function in AML and could uncover an entirely new mechanism of drug resistance. My work will expose the molecular network underpinning TEAD function, potentially revealing new therapeutic targets that could thwart drug resistance and improve patient survival in the clinic.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, Ming-Heng
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~